(19)
(11) EP 4 291 496 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
26.03.2025 Bulletin 2025/13

(45) Mention of the grant of the patent:
29.01.2025 Bulletin 2025/05

(21) Application number: 22705877.3

(22) Date of filing: 18.01.2022
(51) International Patent Classification (IPC): 
B65D 1/02(2006.01)
 B65D 51/00(2006.01)
(52) Cooperative Patent Classification (CPC):
B65D 1/0246; B65D 51/002
(86) International application number:
PCT/IB2022/050393
(87) International publication number:
WO 2022/172101 (18.08.2022 Gazette 2022/33)

(54)

BOTTLE FOR A CONTAINER FOR PARENTERALLY ADMINISTRABLE PHARMACEUTICAL PRODUCTS

FLASCHE FÜR EINEN BEHÄLTER FÜR PARENTERAL VERABREICHBARE PHARMAZEUTISCHE PRODUKTE

BOUTEILLE SERVANT DE CONTENANT POUR PRODUITS PHARMACEUTIQUES ADMINISTRABLES PAR VOIE PARENTÉRALE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 12.02.2021 IT 202100003188

(43) Date of publication of application:
20.12.2023 Bulletin 2023/51

(73) Proprietor: Guala Dispensing FP S.p.a.
15121 Alessandria (IT)

(72) Inventor:
  • ARCURI, Matteo
    15121 Alessandria (IT)

(74) Representative: Gualeni, Nadia 
Jacobacci & Partners S.p.A. Piazza della Vittoria, 11
25122 Brescia
25122 Brescia (IT)


(56) References cited: : 
US-A1- 2016 184 182
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).